Law Debenture investment trust increases AstraZeneca and GSK holdings | October factsheet

LWDB

Law Debenture Corporation plc (LON:LWDB) has announced its fact sheet as at 30th October 2026:

Fund Managers’ Comments

In October the Trust’s NAV fell 0.6%, underperforming the FTSE All-Share benchmark which rose 1.1%. In a backdrop where the oil price rose and the sustainability of AI capital expenditure was being questioned, there was a sharp rotation in markets with defensive sectors outperforming. Oil producers such as Shell and BP performed well (both share prices rose 13-14% in October), as did data services companies Relx and LSEG (where the share prices rose 20% and 16% respectively). While Relx and LSEG had been seen as at risk of AI disintermediation earlier in the year, a further set of encouraging quarterly results led to a sharp relief rally. In contrast, cyclical sectors such as industrials performed poorly, as investors questioned whether rising input costs and a potential slowdown in AI capex would suppress future earnings growth. Industrial holdings such as Hill & Smith therefore performed poorly. Aside from industrials, the key detractors
from the portfolio compared to its FTSE All-Share benchmark were holding less in large index weights that performed well, such as Shell and AstraZeneca, and holding more in AI-exposed next generation energy companies, for example fuel cell developer Ceres Power. We had taken substantial profits in Ceres earlier this calendar year, and the position size is now modest at less than 1%.

From a transactions perspective, within the healthcare sector we sold the positions in Swiss pharmaceutical Roche and US medical devices company Becton Dickinson following good performance. The proceeds were partially rotated into AstraZeneca and GSK. In the case of AstraZeneca, following the initial purchase last month we have continued to gradually add to the holding, while in the case of GSK we added on what we saw as an overreaction to a largely in line set of
quarterly results.

James Henderson and Laura Foll
Janus Henderson

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Law Debenture investment trust increases AstraZeneca and GSK holdings | October factsheet

Law Debenture Corporation continued to reposition its portfolio in October, taking profits from Roche and Becton Dickinson while increasing...

Pension trustees urged to strengthen AI oversight as adoption grows

AI adoption across the pensions industry reaches 100% among surveyed respondents, increasing the focus on governance, member data protection...

Law Debenture completes £2.4bn Royal Mail pension transfer covering 100,000 members

Law Debenture has completed the transfer of £2.4bn in Royal Mail defined contribution pension assets covering approximately 100,000 members...

Six key challenges reshaping pension scheme governance

Six key challenges are reshaping pension scheme governance, from regulatory requirements and trustee succession to administration risks and Master...

UK pension reforms raise new challenges for DC schemes and employers

Law Debenture examines UK DC pension reforms, master trust governance and the inheritance tax changes affecting unused pension funds...

Law Debenture highlights opportunities to unlock value from university pension schemes

Law Debenture identifies opportunities for universities to reduce pension costs, lower employer contributions and release surplus funds from self-administered...

Search